The June meeting was scheduled after expedited approval was denied. The Food and Drug Administration (FDA) announced this week that it has scheduled a meeting of the Peripheral…
Read MoreDepartment of Health and Human Services
HHS Begins Final Round of Pregnancy Hypertension Research
11 projects were selected to refine the care process into reproducible steps. The Department of Health and Human Services (HHS) kicked off the final round of its research…
Read More
FDA Approves Treatment for Uncomplicated UTIs
The medication, Pivya, is now an option for women with uncomplicated urinary tract infections. The Food and Drug Administration (FDA) approved Pivya tablets for treating uncomplicated urinary tract…
Read More
HHS Postpones Menthol Cigarette Ban
Public health advocates question the delay and civil rights groups are concerned with minority health. The Department of Health and Human Services (HHS) recently moved back the implementation…
Read More
Kimryn Rathmell, Director, National Cancer Institute
Kimryn Rathmell, Director, National Cancer Institute
Read More
Legislators Urge DEA to Remove Marijuana from Schedule I
A group of senators and representatives write to the attorney general and DEA administrator. Senators Elizabeth Warren of Massachusetts and John Fetterman of Pennsylvania, and Representatives Barbara Lee…
Read MoreMelanie Rainer, Department of Health & Human Services
Melanie Rainer is the Director of the Office for Civil Rights at the U.S. Department of Health & Human Services. We pray that God will guide her as…
Read More
Melanie Rainer, Director, Office for Civil Rights, Department of Health and Human Services
Melanie Rainer, Director, Office for Civil Rights, Department of Health and Human Services
Read More
HHS Finalizes Protections for Medicare Prescription Plan Enrollees
The provision establishes a set amount of compensation for healthcare agents and brokers. The Department of Health and Human Services (HHS) released a final action plan to better…
Read More
FDA Approves Duchenne Muscular Dystrophy Treatment for Children
Duvyzat receives approval under fast-track designation. The U.S. Food and Drug Administration (FDA) has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne Muscular Dystrophy…
Read More